Fust Matthew K

Director at CRNX; Director at NMRA; Director at RARE, and 4 more

Sold, on record
$15.2M
Dollars the filings state
Form 4 sales
39
Latest Sep 26, 2025
Form 144 notices
4
Proposed sales
Companies
7
Filed as an executive or holder

Companies

Sales by reason

0
Routine
0
Plan not stated
0
No plan
0
Unusual
Stacked: routine sales under a plan, sales whose filing does not state a plan, sales with no plan, and unusual sales.

Form 4 sales per month, last 12 months.

Sales chart range

Sales by company

Shares sold, every Form 4 sale on record.

Timeline

  1. 1 Form 144 notice RARENotice
    Mar 7, 2024 2024

    Filed to sell 12,195 shares ($620k)

    Fust Matthew K, Director

    10b5-1 planFirst sale on recordFiling

  2. 2 Form 4 sale RARERoutine
    Mar 7, 2024 same day

    Sold 12,195 shares at $50.88 ($620k)

    Fust Matthew K, Director

    10b5-1 planSold 45.1% of holdings ($1.4M position)14,860 shares leftFirst sale on recordFollows a Form 144Filing

  3. 3 Form 144 notice CRNXNotice
    Mar 20, 2024 +13 days

    Filed to sell 60,000 shares ($2.6M)

    Fust Matthew K, Director

    10b5-1 planFiling

  4. 4 Form 4 sale CRNXRoutine
    Mar 20, 2024 same day

    Sold 60,000 shares at $44.14 ($2.6M)

    Fust Matthew K, Director

    10b5-1 planSold 76.4% of holdings ($3.5M position)18,536 shares leftFollows a Form 144Filing

  5. 5 Form 144 notice NMRANotice
    Oct 17, 2024 +211 days

    Filed to sell 7,739 shares ($132k)

    Fust Matthew K, Director

    10b5-1 planFirst sale on recordFiling

  6. 6 Form 144 notice NMRANotice
    Oct 18, 2024 +1 day

    Filed to sell 14,049 shares ($239k)

    Fust Matthew K, Director

    10b5-1 planFirst sale on recordFiling

  7. 7 Form 4 sale NMRARoutine
    Oct 18, 2024 same day

    Sold 21,788 shares at $17.02 ($371k)

    Fust Matthew K, Director

    10b5-1 planSold 52% of holdings ($713k position)20,100 shares leftFirst sale on recordFollows a Form 144Filing

  8. 8 Form 4 sale CRNXRoutine
    Sep 26, 2025 +343 days

    Sold 16,000 shares at $44.75 ($716k)

    Fust Matthew K, Director

    10b5-1 planSold 41.2% of holdings ($1.7M position)22,836 shares leftFiling

Every transaction

Loading transactions…

Sales and notices (43)

Form 144 notices and Form 4 sales by Fust Matthew K
Source
Sep 26, 2025Sep 30, 2025CRNXDirectorForm 4 sale16,000$716k41.2%RoutineSEC
Oct 18, 2024Oct 18, 2024NMRADirectorForm 4 sale21,788$371k52.0%RoutineSEC
Oct 18, 2024Oct 18, 2024NMRADirectorForm 144 notice14,049$239kNoticeSEC
Oct 17, 2024Oct 17, 2024NMRADirectorForm 144 notice7,739$132kNoticeSEC
Mar 20, 2024Mar 22, 2024CRNXDirectorForm 4 sale60,000$2.6M76.4%RoutineSEC
Mar 20, 2024Mar 20, 2024CRNXDirectorForm 144 notice60,000$2.6MNoticeSEC
Mar 7, 2024Mar 11, 2024RAREDirectorForm 4 sale12,195$620k45.1%RoutineSEC
Mar 7, 2024Mar 7, 2024RAREDirectorForm 144 notice12,195$620kNoticeSEC
Jul 13, 2022Jul 15, 2022CRNXDirectorForm 4 sale5,700$119k31.3%UnusualSEC
Nov 4, 2021Nov 5, 2021ATRADirectorForm 4 sale13,354$260k29.8%UnusualSEC
Nov 1, 2021Nov 3, 2021CRNXDirectorForm 4 sale8,954$228k41.7%UnusualSEC
Sep 8, 2021Sep 9, 2021CRNXDirectorForm 4 sale6,046$154k32.5%UnusualSEC
Jul 26, 2021Jul 27, 2021CRNXDirectorForm 4 sale5,000$98k28.5%UnusualSEC
Jul 19, 2021Jul 20, 2021CRNXDirectorForm 4 sale5,000$98k28.5%UnusualSEC
Jul 12, 2021Jul 13, 2021CRNXDirectorForm 4 sale5,000$104k28.5%UnusualSEC
Jul 6, 2020Jul 8, 2020RAREDirectorForm 4 sale6,181$556k31.3%UnusualSEC
Jul 1, 2020Jul 6, 2020RAREDirectorForm 4 sale5,000$425k27.0%UnusualSEC
May 18, 2020May 19, 2020RAREDirectorForm 4 sale1,875$141k14.6%Plan not statedSEC
Apr 22, 2020Apr 24, 2020RAREDirectorForm 4 sale1,875$122k12.7%Plan not statedSEC
Dec 24, 2019Dec 26, 2019Dermira, Inc.DirectorForm 4 sale3,000$45k37.3%UnusualSEC
Dec 16, 2019Dec 18, 2019CRNXDirectorForm 4 sale3,500$79k21.8%Plan not statedSEC
Dec 12, 2019Dec 13, 2019Dermira, Inc.DirectorForm 4 sale3,000$36k27.1%UnusualSEC
Sep 12, 2019Sep 16, 2019Dermira, Inc.DirectorForm 4 sale6,000$53k35.2%UnusualSEC
Feb 6, 2019Feb 8, 2019MGNXDirectorForm 4 sale6,924$203k93.3%UnusualSEC
Oct 19, 2018Oct 19, 2018Dermira, Inc.DirectorForm 4 sale4,000$55k22.2%Plan not statedSEC
May 30, 2018May 30, 2018RAREDirectorForm 4 sale6,319$455k41.9%UnusualSEC
May 14, 2018May 16, 2018ATRADirectorForm 4 sale12,286$535k38.3%UnusualSEC
Aug 8, 2013Aug 12, 2013ONYX PHARMACEUTICALS INCEVP & Chief Financial OfficerForm 4 sale2,492$319k5.8%Plan not statedSEC
Jul 26, 2013Jul 29, 2013ONYX PHARMACEUTICALS INCEVP & Chief Financial OfficerForm 4 sale6,043$789k12.4%Plan not statedSEC
Jul 2, 2013Jul 5, 2013ONYX PHARMACEUTICALS INCEVP & Chief Financial OfficerForm 4 sale1,551$206k3.1%Plan not statedSEC
May 13, 2013May 15, 2013ONYX PHARMACEUTICALS INCEVP & Chief Financial OfficerForm 4 sale10,269$1M17.0%Plan not statedSEC
Apr 15, 2013Apr 16, 2013ONYX PHARMACEUTICALS INCEVP & Chief Financial OfficerForm 4 sale1,347$128k2.6%Plan not statedSEC
Apr 1, 2013Apr 3, 2013ONYX PHARMACEUTICALS INCEVP & Chief Financial OfficerForm 4 sale3,861$333k7.0%Plan not statedSEC
Feb 28, 2013Mar 4, 2013ONYX PHARMACEUTICALS INCEVP & Chief Financial OfficerForm 4 sale15,000$1.2M24.9%UnusualSEC
Jan 10, 2013Jan 11, 2013ONYX PHARMACEUTICALS INCEVP & Chief Financial OfficerForm 4 sale10,199$866k16.9%UnusualSEC
Aug 6, 2012Aug 8, 2012ONYX PHARMACEUTICALS INCChief Financial OfficerForm 4 sale22,009$1.6M25.8%UnusualSEC
Jul 25, 2012Jul 27, 2012ONYX PHARMACEUTICALS INCChief Financial OfficerForm 4 sale5,207$385k7.1%UnusualSEC
Mar 2, 2012Mar 6, 2012ONYX PHARMACEUTICALS INCChief Financial OfficerForm 4 sale592$22k1.2%Plan not statedSEC
Jan 6, 2012Jan 10, 2012ONYX PHARMACEUTICALS INCChief Financial OfficerForm 4 sale1,789$78k3.9%Plan not statedSEC
Nov 18, 2011Nov 21, 2011ONYX PHARMACEUTICALS INCChief Financial OfficerForm 4 sale867$33k1.9%Plan not statedSEC
Apr 1, 2011Apr 4, 2011ONYX PHARMACEUTICALS INCChief Financial OfficerForm 4 sale800$28k1.7%Plan not statedSEC
Jan 6, 2011Jan 7, 2011ONYX PHARMACEUTICALS INCChief Financial OfficerForm 4 sale1,812$68k9.1%Plan not statedSEC
Jan 6, 2010Jan 7, 2010ONYX PHARMACEUTICALS INCChief Financial OfficerForm 4 sale1,919$57k14.2%Plan not statedSEC